Published in Osteoporos Int on June 01, 2005
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr (2012) 3.48
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37
Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab (2009) 3.27
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ (2011) 2.97
Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ (2009) 2.90
Relationship of obesity with osteoporosis. J Clin Endocrinol Metab (2007) 2.71
The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int (2009) 2.61
Relationships between fat and bone. Osteoporos Int (2007) 2.51
Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res (2008) 2.40
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11
Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res (2008) 2.07
Appropriate osteoporosis treatment by family physicians in response to FRAX vs CAROC reporting: results from a randomized controlled trial. J Clin Densitom (2013) 2.05
Development and use of FRAX in osteoporosis. Osteoporos Int (2010) 2.04
Causal relationship between the AHSG gene and BMD through fetuin-A and BMI: multiple mediation analysis. Osteoporos Int (2014) 2.02
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88
The utility and limitations of FRAX: A US perspective. Curr Osteoporos Rep (2010) 1.84
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study. J Bone Miner Res (2009) 1.71
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer. J Urol (2010) 1.66
Simply ask them about their balance--future fracture risk in a nationwide cohort study of twins. Am J Epidemiol (2008) 1.65
A losing battle: weight regain does not restore weight loss-induced bone loss in postmenopausal women. Obesity (Silver Spring) (2011) 1.61
Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int (2007) 1.61
Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes. Diabetes Care (2009) 1.54
BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res (2011) 1.51
Fracture Risk and Risk Factors for Osteoporosis. Dtsch Arztebl Int (2015) 1.51
The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J (2007) 1.51
Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int (2010) 1.42
UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos (2017) 1.40
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int (2008) 1.39
Weight management and its role in breast cancer rehabilitation. Cancer (2012) 1.39
Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res (2010) 1.35
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int (2009) 1.33
Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int (2010) 1.29
Bone metabolism in obesity and weight loss. Annu Rev Nutr (2012) 1.28
A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab (2008) 1.26
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009. Int J Gen Med (2010) 1.22
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res (2014) 1.19
Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ (2012) 1.17
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2010) 1.17
Continuous decline in incidence of hip fracture: nationwide statistics from Finland between 1970 and 2010. Osteoporos Int (2012) 1.16
Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int (2008) 1.15
Coffee consumption and bone mineral density in korean premenopausal women. Korean J Fam Med (2014) 1.14
Divergent effects of obesity on fragility fractures. Clin Interv Aging (2014) 1.14
Gender-specific associations between soy and risk of hip fracture in the Singapore Chinese Health Study. Am J Epidemiol (2009) 1.13
Lean mass and not fat mass is associated with male proximal femur strength. J Bone Miner Res (2008) 1.13
Relationship of body mass index with main limb fragility fractures in postmenopausal women. J Bone Miner Metab (2009) 1.13
Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int (2012) 1.13
Fracture risk following bariatric surgery: a population-based study. Osteoporos Int (2013) 1.13
Type 2 diabetes and bone fractures. Curr Opin Endocrinol Diabetes Obes (2012) 1.12
BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int (2009) 1.12
Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot. Phys Ther (2008) 1.11
Multifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women. Arch Med Sci (2012) 1.11
Impact of increased overweight on the projected prevalence of osteoporosis in older women. Osteoporos Int (2006) 1.11
Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int (2008) 1.11
Associations of fat mass and fat distribution with bone mineral density in pre- and postmenopausal Chinese women. Osteoporos Int (2010) 1.09
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int (2011) 1.08
Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int (2010) 1.07
Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study. J Clin Endocrinol Metab (2011) 1.07
Body mass index and risk of adverse cardiac events in elderly patients with hip fracture: a population-based study. J Am Geriatr Soc (2009) 1.07
The Osteoporosis Self-Assessment Tool versus alternative tests for selecting postmenopausal women for bone mineral density assessment: a comparative systematic review of accuracy. Osteoporos Int (2008) 1.05
Ethnic differences in femur geometry in the women's health initiative observational study. Osteoporos Int (2010) 1.05
The role of body mass index, insulin, and adiponectin in the relation between fat distribution and bone mineral density. Calcif Tissue Int (2009) 1.04
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy. J Gen Intern Med (2009) 1.03
Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporos Int (2011) 1.02
Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep (2010) 1.01
Reduced size-independent mechanical properties of cortical bone in high-fat diet-induced obesity. Bone (2009) 1.01
Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res (2012) 1.01
Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX. Osteoporos Int (2009) 1.00
Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res (2011) 1.00
Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice. Osteoporos Int (2010) 1.00
Determinants of fracture risk in a UK-population-based cohort of older women: a cross-sectional analysis of the Cohort for Skeletal Health in Bristol and Avon (COSHIBA). Age Ageing (2011) 0.99
Association between functional capacity tests and fractures: an eight-year prospective population-based cohort study. Osteoporos Int (2008) 0.99
Trochanteric soft tissue thickness and hip fracture in older men. J Clin Endocrinol Metab (2008) 0.99
High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab (2009) 0.99
The epidemic of hip fractures: are we on the right track? PLoS One (2011) 0.99
Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies. Curr Osteoporos Rep (2012) 0.99
The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int (2009) 0.98
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol (2012) 0.97
Bone health and prostate cancer. Prostate Cancer Prostatic Dis (2009) 0.97
Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? Ther Clin Risk Manag (2015) 0.96
Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study. Osteoporos Int (2011) 0.95
The discriminatory capacity of BMD measurements by DXA and dual X-ray and laser (DXL) at the calcaneus including clinical risk factors for detecting patients with vertebral fractures. Osteoporos Int (2013) 0.95
The role of leptin in regulating bone metabolism. Metabolism (2014) 0.95
Body mass index and disease burden in elderly men and women: the Tromsø Study. Eur J Epidemiol (2010) 0.95
Association between bone mineral density, lean mass, and fat mass among healthy middle-aged premenopausal women: a cross-sectional study in southern Sri Lanka. J Bone Miner Metab (2008) 0.94
Different effects of age, adiposity and physical activity on the risk of ankle, wrist and hip fractures in postmenopausal women. Bone (2012) 0.94
A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int (2010) 0.94
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67
Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med (2003) 5.38
Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res (2003) 4.15
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet (1996) 3.18
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80
Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res (2000) 2.24
Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int (1994) 1.95
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res (2003) 1.56
Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res (1998) 1.51
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults. Am J Epidemiol (1993) 1.43
Bone mineral density is a predictor of survival. Calcif Tissue Int (1998) 1.32
Risk factors for hip fracture in a Japanese cohort. J Bone Miner Res (1997) 1.26
Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res (2003) 1.20
Fractured neck of femur in the elderly: an attempt to identify patients at risk. Clin Sci (Lond) (1979) 1.16
Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int (2001) 1.14
Optimization of BMD measurements to identify high risk groups for treatment--a test analysis. J Bone Miner Res (2004) 1.05
Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. Osteoporos Int (1998) 1.01
Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. J Bone Miner Res (2000) 1.01
Risk factors for perimenopausal distal forearm fracture. Osteoporos Int (2000) 0.96
Seventy-year-old people in Gothenburg a population study in an industrialized Swedish city. II. General presentation of social and medical conditions. Acta Med Scand Suppl (1977) 0.93
The Tromsø Study: body height, body mass index and fractures. Osteoporos Int (1998) 0.92
Spinal osteoporosis and femoral neck fracture. Clin Orthop Relat Res (1970) 0.86
Factors associated with time to first hip fracture. J Aging Health (2001) 0.81
Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss? Osteoporos Int (2003) 0.78
Osteoporosis diagnosis and fracture. Orthop Nurs (2000) 0.76
Differences in body composition between female geriatric hip fracture patients and healthy controls: body fat is more important as explanatory factor for the fracture than body weight and lean body mass. Aging (Milano) (1996) 0.76
Factors related to occurrence of hip fracture during a fall on the hip. Public Health (2003) 0.76
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Involutional osteoporosis. N Engl J Med (1986) 8.20
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
15-year longitudinal study of blood pressure and dementia. Lancet (1996) 6.44
Statistical methods for assessing observer variability in clinical measures. BMJ (1992) 6.24
Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int (1997) 5.82
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17
Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum (2007) 4.97
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int (2004) 4.24
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet (1995) 3.82
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis (2007) 3.70
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
Bone densitometry in clinical practice. BMJ (1995) 3.48
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
The prevalence of chronic widespread pain in the general population. J Rheumatol (1993) 3.29
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet (1996) 3.18
Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy. J Lab Clin Med (1998) 3.18
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08